Ilsung Is Co., Ltd. (KRX:003120)

South Korea flag South Korea · Delayed Price · Currency is KRW
23,450
-300 (-1.26%)
Last updated: Dec 4, 2025, 9:00 AM KST
44.57%
Market Cap 162.38B
Revenue (ttm) 66.51B
Net Income (ttm) 2.32B
Shares Out 6.97M
EPS (ttm) n/a
PE Ratio 69.91
Forward PE n/a
Dividend 1,000.00 (4.26%)
Ex-Dividend Date Dec 29, 2025
Volume 4,246
Average Volume 8,670
Open 23,950
Previous Close 23,750
Day's Range 23,450 - 23,950
52-Week Range 14,500 - 31,450
Beta -0.32
RSI 49.54
Earnings Date Nov 14, 2025

About Ilsung Is

Ilsung Is Co., Ltd. operates as a pharmaceutical company in South Korea. Its products include antibiotics, analgesics, muscle relaxants, antipyretic-analgesics, antihistamine, neuropsychiatric, neuromuscular blocker/ central muscle relaxants, anti-coagulants, probiotics, vaccine, medical equipment, circulatory system drugs, contrast agents, muscle relaxants, diabetes treatments, osteopathic, digestive system medicines, anti-virals, anti-emetics, respiratory treatments, adrenal cortical steroids, anesthetics, antipyretics, and cardiovascular sys... [Read more]

Sector Healthcare
Founded 1954
Country South Korea
Stock Exchange Korea Stock Exchange
Ticker Symbol 003120
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.